Implications of bilateral free trade agreements on access to medicines
The TRIPS Agreement of the World Trade Organization (WTO) mandated the introduction of protection of intellectual property rights, notably patents, for pharmaceutical products. While the implications for the access to medicines contained in the terms of this Agreement raised significant concerns, a...
Saved in:
Main Author: | Correa Carlos María (Author) |
---|---|
Format: | Book |
Published: |
The World Health Organization,
2006-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Free-trade agreements: challenges for global health
by: Helena Ribeiro
Published: (2015) - Study on the health implications of trade agreements published
-
Effect of free trade agreements on pharmaceutical market competition: The case of the 2009 US-Peru free trade agreement and its implementation as national drug policy
by: Lita Araujo, et al.
Published: (2021) -
Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy
by: Searles Andrew, et al.
Published: (2005) -
Potential Benefits of an Australia-EU Free Trade Agreement Key Issues and Options
Published: (2018)